Ocean Bio Chem Inc (OBCI) 2.23 $OBCI
Ocean Bio-Chem, Inc. Reports: 2016 First Quarter Financial Results
PR Newswire - Mon May 16, 9:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the first quarter of 2016, including first quarter net sales of $6.75 million, a record for the first quarter and $748,000 or 12.5 percent higher than sales of approximately $6 million in the same period in 2015.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Declares Special Cash Dividend of $0.06 Per Share, 2015 Financial Results Reported
PR Newswire - Thu Mar 31, 7:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its Board of Directors has declared a special cash dividend of $0.06 per share, payable on April 26, 2016 to holders of record of the Company's common stock on April 12, 2016.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s PERFORMACIDE®: The Answer to Kill Viruses and Bacteria at Hospitals, Emergency Rooms, and on Home Care Equipment
PR Newswire - Tue Mar 15, 9:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) subsidiary Odorstar Technology, LLC announced that the use of its PERFORMACIDE® disinfectant is an effective disinfectant for use on hard non-porous surfaces that can transfer drug resistant Gram-negative bacterium in medical facilities and on home health care equipment. The Center for Disease Control (CDC) is currently investigating 18 recent deaths in the state of Wisconsin tied to Elizabethkingia anopheles, a Gram-negative bacterium that can cause pneumonia, and blood stream infections. Gram-negative bacteria can be resistant to multiple drugs and are becoming increasingly resistant to most available antibiotics. PERFORMACIDE® is a hospital grade disinfectant that utilizes activated chlorine dioxide (CLO2) and is effective as a disinfectant against Gram-negative bacterium such as pseudomonas aeruginosa and as a sanitizer against klebsiella pneumonia, and E-Coli.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Says Federal Jury Denies False Advertising Claims
PR Newswire - Wed Mar 09, 12:30PM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) is pleased to announce that in a lawsuit in the Federal Court, Southern District of Florida, a jury has found that Ocean Bio-Chem's subsidiary, Star brite, did not engage in false advertising concerning its flagship product, Star Tron - Enzyme Fuel Treatment.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem wins OMRI approval to use organic materials review institute seal on PERFORMACIDE
M2 - Wed Jan 06, 5:56AM CST
Marine maintenance company Ocean Bio-Chem (NasdaqCM:OBCI) reported on Tuesday that it has received approval to use the Organic Materials Review Institute (OMRI) seal on its PERFORMACIDE Chlorine Dioxide (CLO2) Generator System Disinfectant for Hard, Non-Porous Surfaces.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Receives Approval to Use Organic Materials Review Institute Seal on PERFORMACIDE®
PR Newswire - Tue Jan 05, 10:00AM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) today announced that its wholly owned subsidiary, Odorstar, LLC, has received approval to use the Organic Materials Review Institute (OMRI) seal on its PERFORMACIDE® Chlorine Dioxide (CLO2) Generator System Disinfectant for Hard, Non-Porous Surfaces. The OMRI seal means that the product may be used in certified organic production or food processing and handling, according to the United States Department of Agriculture (USDA) National Organic Program.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Third Quarter 2015 Financial Results
PR Newswire - Fri Nov 13, 8:15AM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the three and nine months ended September 30, 2015, including record net sales.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Announces: Distribution Agreement with Davis Manufacturing Veterinary Products for Performacide®
PR Newswire - Tue Sep 15, 12:00PM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), announced today its wholly owned subsidiary Star brite®, signed a Distribution Agreement with Davis Manufacturing Veterinary Products. Davis will serve as a distributor for Star brite's Performacide® Hard Surface Disinfectant into the Pet, Veterinary and Poultry markets.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Second Quarter 2015 Financial Results
PR Newswire - Fri Aug 14, 9:00AM CDT
Ocean Bio-Chem, Inc. (NASDAQ OBCI) announced today its operating results for the three and six months ended June 30, 2015. Net income for the second quarter of 2015 was approximately $114,000, or $0.01 per common share, compared to $411,000 or $0.05 per common share, for the second quarter of 2014.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s Disinfectant Product PERFORMACIDE® Can Prevent Norovirus, A Major Cause of Disease Outbreaks
PR Newswire - Thu Jul 16, 8:45AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), today said its PERFORMACIDE® hard surface disinfectant is registered with the U.S. Environmental Protection Agency against norovirus, the number one cause of disease outbreak caused by contaminated food in the U.S.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Is Added to Russell Microcap Index
PR Newswire - Mon Jul 06, 8:00AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), today announced that it has been added to the Russell Microcap Index. This follows the annual reconstitution of the comprehensive set of U.S. and global equity indexes produced by Russell Investments.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s. Star brite® Products Featured in Videos as Boating Season Gets Serious
PR Newswire - Mon Jun 15, 9:30AM CDT
With boating season getting into full swing as summer approaches and the weather warms up, Ocean Bio-Chem, Inc. (NASDAQ: OBCI), subsidiary Star brite, Inc. - is proud to present educational videos about the use of its products at: http://www.starbrite.com/videos/star-brite-solutions-en.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem Urges Use of Its Disinfectant to Protect Against Widespread Impact of Bird Flu
PR Newswire - Wed May 20, 8:00AM CDT
With the announcement that Nebraska is the fourth state to declare a state of emergency because of the outbreak of Avian Flu, Ocean Bio-Chem, Inc. (NASDAQ: OBCI), repeated its public announcement that its PERFORMACIDE® Hard Surface Disinfectant is the perfect choice to disinfect frequently touched surfaces and objects.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Releases Update On Use Of PERFORMACIDE To Control Bird Flu Infections
PR Newswire - Tue Apr 28, 10:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI),-- Released the following today: Based on the current outbreaks of Avian Flu, The Center for Disease Control (CDC) has issued interim guidance on testing, specimen collection, and processing of patients with suspected infections with Novel Influenza A viruses with the potential to cause severe disease in humans. In this guidance the CDC recommends disinfecting frequently touched surfaces with EPA Disinfectants labeled to kill Influenza A. The CDC also recommends that clinicians and public health personnel consider the possibility of infection in anyone with influenza-like illnesses (ILI), and acute respiratory infection (ARI), that has had contact with sick or dead birds, in the following categories, domestic poultry (e.g., chickens, turkeys, ducks), wild aquatic birds (e.g., ducks, geese, swans), and captive birds (e.g., falcons) that have had contact with wild aquatic birds.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Record Fourth Quarter and Full Year 2014 Net Income
PR Newswire - Tue Mar 31, 6:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) reported record net income in the fourth quarter of 2014 of approximately $511,000, compared to net income of approximately $318,000 in the fourth quarter of 2013, an increase of 61% or $193,000. Basic and diluted earnings per share in the fourth quarter of 2014 were $0.06, compared to basic and diluted earnings per share of $0.04 for the comparative 2013 period. The Company also reported record fourth quarter net sales of approximately $8.8 million, compared to approximately $7.8 million for the fourth quarter of 2013, an increase of approximately 13%.
OBCI: 2.23 (+0.10)
15.7% Return Seen to Date on SmarTrend Ocean Bio-Chem Call (OBCI)
Comtex SmarTrend(R) - Wed Feb 18, 9:29AM CST
SmarTrend identified an Uptrend for Ocean Bio-Chem (NASDAQ:OBCI) on December 19th, 2014 at $4.75. In approximately 2 months, Ocean Bio-Chem has returned 15.70% as of today's recent price of $5.49.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports: 2016 First Quarter Financial Results
PR Newswire - Mon May 16, 9:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the first quarter of 2016, including first quarter net sales of $6.75 million, a record for the first quarter and $748,000 or 12.5 percent higher than sales of approximately $6 million in the same period in 2015.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Declares Special Cash Dividend of $0.06 Per Share, 2015 Financial Results Reported
PR Newswire - Thu Mar 31, 7:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today that its Board of Directors has declared a special cash dividend of $0.06 per share, payable on April 26, 2016 to holders of record of the Company's common stock on April 12, 2016.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s PERFORMACIDE®: The Answer to Kill Viruses and Bacteria at Hospitals, Emergency Rooms, and on Home Care Equipment
PR Newswire - Tue Mar 15, 9:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) subsidiary Odorstar Technology, LLC announced that the use of its PERFORMACIDE® disinfectant is an effective disinfectant for use on hard non-porous surfaces that can transfer drug resistant Gram-negative bacterium in medical facilities and on home health care equipment. The Center for Disease Control (CDC) is currently investigating 18 recent deaths in the state of Wisconsin tied to Elizabethkingia anopheles, a Gram-negative bacterium that can cause pneumonia, and blood stream infections. Gram-negative bacteria can be resistant to multiple drugs and are becoming increasingly resistant to most available antibiotics. PERFORMACIDE® is a hospital grade disinfectant that utilizes activated chlorine dioxide (CLO2) and is effective as a disinfectant against Gram-negative bacterium such as pseudomonas aeruginosa and as a sanitizer against klebsiella pneumonia, and E-Coli.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Says Federal Jury Denies False Advertising Claims
PR Newswire - Wed Mar 09, 12:30PM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) is pleased to announce that in a lawsuit in the Federal Court, Southern District of Florida, a jury has found that Ocean Bio-Chem's subsidiary, Star brite, did not engage in false advertising concerning its flagship product, Star Tron - Enzyme Fuel Treatment.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem wins OMRI approval to use organic materials review institute seal on PERFORMACIDE
M2 - Wed Jan 06, 5:56AM CST
Marine maintenance company Ocean Bio-Chem (NasdaqCM:OBCI) reported on Tuesday that it has received approval to use the Organic Materials Review Institute (OMRI) seal on its PERFORMACIDE Chlorine Dioxide (CLO2) Generator System Disinfectant for Hard, Non-Porous Surfaces.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Receives Approval to Use Organic Materials Review Institute Seal on PERFORMACIDE®
PR Newswire - Tue Jan 05, 10:00AM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) today announced that its wholly owned subsidiary, Odorstar, LLC, has received approval to use the Organic Materials Review Institute (OMRI) seal on its PERFORMACIDE® Chlorine Dioxide (CLO2) Generator System Disinfectant for Hard, Non-Porous Surfaces. The OMRI seal means that the product may be used in certified organic production or food processing and handling, according to the United States Department of Agriculture (USDA) National Organic Program.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Third Quarter 2015 Financial Results
PR Newswire - Fri Nov 13, 8:15AM CST
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today its financial results for the three and nine months ended September 30, 2015, including record net sales.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Announces: Distribution Agreement with Davis Manufacturing Veterinary Products for Performacide®
PR Newswire - Tue Sep 15, 12:00PM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), announced today its wholly owned subsidiary Star brite®, signed a Distribution Agreement with Davis Manufacturing Veterinary Products. Davis will serve as a distributor for Star brite's Performacide® Hard Surface Disinfectant into the Pet, Veterinary and Poultry markets.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Second Quarter 2015 Financial Results
PR Newswire - Fri Aug 14, 9:00AM CDT
Ocean Bio-Chem, Inc. (NASDAQ OBCI) announced today its operating results for the three and six months ended June 30, 2015. Net income for the second quarter of 2015 was approximately $114,000, or $0.01 per common share, compared to $411,000 or $0.05 per common share, for the second quarter of 2014.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s Disinfectant Product PERFORMACIDE® Can Prevent Norovirus, A Major Cause of Disease Outbreaks
PR Newswire - Thu Jul 16, 8:45AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), today said its PERFORMACIDE® hard surface disinfectant is registered with the U.S. Environmental Protection Agency against norovirus, the number one cause of disease outbreak caused by contaminated food in the U.S.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Is Added to Russell Microcap Index
PR Newswire - Mon Jul 06, 8:00AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI), today announced that it has been added to the Russell Microcap Index. This follows the annual reconstitution of the comprehensive set of U.S. and global equity indexes produced by Russell Investments.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc.'s. Star brite® Products Featured in Videos as Boating Season Gets Serious
PR Newswire - Mon Jun 15, 9:30AM CDT
With boating season getting into full swing as summer approaches and the weather warms up, Ocean Bio-Chem, Inc. (NASDAQ: OBCI), subsidiary Star brite, Inc. - is proud to present educational videos about the use of its products at: http://www.starbrite.com/videos/star-brite-solutions-en.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem Urges Use of Its Disinfectant to Protect Against Widespread Impact of Bird Flu
PR Newswire - Wed May 20, 8:00AM CDT
With the announcement that Nebraska is the fourth state to declare a state of emergency because of the outbreak of Avian Flu, Ocean Bio-Chem, Inc. (NASDAQ: OBCI), repeated its public announcement that its PERFORMACIDE® Hard Surface Disinfectant is the perfect choice to disinfect frequently touched surfaces and objects.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Releases Update On Use Of PERFORMACIDE To Control Bird Flu Infections
PR Newswire - Tue Apr 28, 10:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI),-- Released the following today: Based on the current outbreaks of Avian Flu, The Center for Disease Control (CDC) has issued interim guidance on testing, specimen collection, and processing of patients with suspected infections with Novel Influenza A viruses with the potential to cause severe disease in humans. In this guidance the CDC recommends disinfecting frequently touched surfaces with EPA Disinfectants labeled to kill Influenza A. The CDC also recommends that clinicians and public health personnel consider the possibility of infection in anyone with influenza-like illnesses (ILI), and acute respiratory infection (ARI), that has had contact with sick or dead birds, in the following categories, domestic poultry (e.g., chickens, turkeys, ducks), wild aquatic birds (e.g., ducks, geese, swans), and captive birds (e.g., falcons) that have had contact with wild aquatic birds.
OBCI: 2.23 (+0.10)
Ocean Bio-Chem, Inc. Reports Record Fourth Quarter and Full Year 2014 Net Income
PR Newswire - Tue Mar 31, 6:30AM CDT
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) reported record net income in the fourth quarter of 2014 of approximately $511,000, compared to net income of approximately $318,000 in the fourth quarter of 2013, an increase of 61% or $193,000. Basic and diluted earnings per share in the fourth quarter of 2014 were $0.06, compared to basic and diluted earnings per share of $0.04 for the comparative 2013 period. The Company also reported record fourth quarter net sales of approximately $8.8 million, compared to approximately $7.8 million for the fourth quarter of 2013, an increase of approximately 13%.
OBCI: 2.23 (+0.10)
15.7% Return Seen to Date on SmarTrend Ocean Bio-Chem Call (OBCI)
Comtex SmarTrend(R) - Wed Feb 18, 9:29AM CST
SmarTrend identified an Uptrend for Ocean Bio-Chem (NASDAQ:OBCI) on December 19th, 2014 at $4.75. In approximately 2 months, Ocean Bio-Chem has returned 15.70% as of today's recent price of $5.49.
OBCI: 2.23 (+0.10)
